Keeping Current CME

by Medscape

Hear from experts as they discuss timely clinical topics as well as relevant and actionable strategies for practice improvement. This podcast is available for CME credit.

Apple Podcasts

Spotify

Episodes

Preparing for Novel Oral Endocrine Therapies in Early Breast CancerPreparing for Novel Oral Endocrine Therapies in Early Breast Cancer

Nov 4

Prepare your practice for the next generation of oral endocrine therapies. Credit available for this activity expires: 11/03/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle//viewarticle/preparing-novel-oral-endocrine-therapies-early-breast-cancer-2026a10015ev?ecd=bdc_podcast_lib…

Nov 4

Best Practices for Focal Epilepsy Control in Closed Systems: Exploring Long-Term Care and VA SettingsBest Practices for Focal Epilepsy Control in Closed Systems: Exploring Long-Term Care and VA Settings

Oct 30

Are subtle focal seizures masking as dementia or stroke in your clinic? Credit available for this activity expires: 10/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/best-practices-focal-epilepsy-control-closed-systems-2026a100155a?ecd=bdc_podcast_libsyn_mscpedu

Oct 30

Shared Voices: The Patient Journey in Obesity-Linked Liver DiseaseShared Voices: The Patient Journey in Obesity-Linked Liver Disease

Oct 30

Explore patient journeys and multidisciplinary care management in obesity-linked liver disease. Credit available for this activity expires: 10/30/27 Earn Credit / Learning Objectives & Disclosures…

Oct 30

Navigating the Data: Patient Eligibility for Novel Oral Therapies in EBCNavigating the Data: Patient Eligibility for Novel Oral Therapies in EBC

Oct 30

Did you know that EBC patients may stop treatment early, due to safety or tolerability, increasing risk of recurrence, hence the need for newer options? Credit available for this activity expires: 10/30/27 Earn Credit / Learning Objectives & Disclosures…

Oct 30

TED Paradigm Shift: Implications of New Treatments and Evolving Care StandardsTED Paradigm Shift: Implications of New Treatments and Evolving Care Standards

Oct 29

Could the latest targeted therapies reshape outcomes for your TED patients? Credit available for this activity expires: 10/29/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/ted-paradigm-shift-implications-new-treatments-and-evolving-2026a10012yt?ecd=bdc_podcast_libsyn_mscpedu

Oct 29

Primary Care Bootcamp in Obstructive Sleep Apnea: Going Beyond the Obvious in Diagnosing OSAPrimary Care Bootcamp in Obstructive Sleep Apnea: Going Beyond the Obvious in Diagnosing OSA

Oct 28

Do you know the spectrum of risk factors associated with obstructive sleep apnea (OSA)? Listen to our expert faculty to learn more. Credit available for this activity expires: 10/27/27 Earn Credit / Learning Objectives & Disclosures…

Oct 28

Moving the Needle on HAE Attacks: Understanding Bradykinin Signaling and Persistent SwellingMoving the Needle on HAE Attacks: Understanding Bradykinin Signaling and Persistent Swelling

Oct 28

Discover the mechanisms responsible for persistent swelling during HAE attacks. Credit available for this activity expires: 10/27/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/moving-needle-hae-attacks-understanding-bradykinin-signaling-2026a10013u8?ecd=bdc_podcast_libsyn_mscp…

Oct 28

Expert Insights on Personalized Care: NTRK Fusion-Positive CNS Cancer, Sarcoma, and Pediatric CancersExpert Insights on Personalized Care: NTRK Fusion-Positive CNS Cancer, Sarcoma, and Pediatric Cancers

Oct 23

How can you optimize personalized care and manage resistance in pediatric NTRK fusion-positive CNS and sarcoma cases? Credit available for this activity expires: 10/23/27 Earn Credit / Learning Objectives & Disclosures…

Oct 23

From TNF Cycling to JAK Inhibitors: Interpreting Evidence to Improve Outcomes in Rheumatoid ArthritisFrom TNF Cycling to JAK Inhibitors: Interpreting Evidence to Improve Outcomes in Rheumatoid Arthritis

Oct 23

New evidence on switching from tumor necrosis factor (TNF) to Janus kinase (JAK) inhibitors for rheumatoid arthritis (RA). Credit available for this activity expires: 10/21/27 Earn Credit / Learning Objectives & Disclosures…

Oct 23

From Pathway to Prescription in Alopecia AreataFrom Pathway to Prescription in Alopecia Areata

Oct 22

Experts discuss new clinical trial data and long-term safety of Janus kinase (JAK) inhibitors in alopecia areata (AA). Credit available for this activity expires: 10/21/27 Earn Credit / Learning Objectives & Disclosures…

Oct 22

The Next Frontier in SLE Management: Integrating Science With Targeted Treatment StrategiesThe Next Frontier in SLE Management: Integrating Science With Targeted Treatment Strategies

Oct 15

Experts discuss recent clinical guidelines and trial data on JAK inhibitors for systemic lupus erythematosus (SLE) treatment. Credit available for this activity expires: 10/15/27 Earn Credit / Learning Objectives & Disclosures…

Oct 15

From Itch to Insight: The Prurigo Nodularis CountdownFrom Itch to Insight: The Prurigo Nodularis Countdown

Oct 13

Experts discuss the latest efficacy and safety data on systemic treatments for prurigo nodularis. Credit available for this activity expires: 10/12/2027 Earn Credit / Learning Objectives & Disclosures…

Oct 13